Evidence map›Paper›PMID 29338055›Full record

ArticlePLoS pathogens2018

A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles.

Robert C C Mercer, Nathalie Daude, Lyudmyla Dorosh, Ze-Lin Fu, Charles E Mays, Hristina Gapeshina, Serene L Wohlgemuth, Claudia Y Acevedo-Morantes, Jing Yang, Neil R Cashman and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Enhanced lysosomal activity prevents infection with PrPThe Journal of biological chemistry · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Quaternary Structure Changes for PrPMolecular neurobiology · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Robert C C MercerCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
Nathalie DaudeCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0001-5217-7826
Lyudmyla DoroshNational Research Council of Canada, Edmonton, Alberta, Canada.ORCID 0000-0002-5224-4045
Ze-Lin FuCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
Charles E MaysCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
Hristina GapeshinaCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
Serene L WohlgemuthCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
Claudia Y Acevedo-MorantesCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
Jing YangCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-0920-972X
Neil R CashmanBrain Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Michael B CoulthartCanadian Creutzfeldt-Jakob Disease Surveillance System, Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Dawn M PearsonDepartment of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0002-7414-2357
Jeffrey T JosephHotchkiss Brain Institute and Calgary Laboratory Services, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-3312-5283
Holger WilleCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0001-5102-8706
Jiri G SafarDepartments of Pathology and Neurology, School of Medicine Case Western Reserve University, Cleveland, Ohio, United States of America.ORCID 0000-0003-2209-0070
Gerard H JansenCanadian Creutzfeldt-Jakob Disease Surveillance System, Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Maria StepanovaNational Research Council of Canada, Edmonton, Alberta, Canada.
Brian D SykesCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0003-2544-2246
David WestawayCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0003-1928-4616
University of Alberta · CAUniversity of Calgary · CACase Western Reserve University · USPublic Health Agency of Canada · CAUniversity of British Columbia · CAUniversity of Ottawa · CA

Funding

Replication mechanism of human prionsR01NS103848 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI SAFAR, JIRI G., SUREWICZ, WITOLD K · 2018 to 2022
$2.6M
Replication mechanism of human prionsR01NS074317 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI SAFAR, JIRI G., SUREWICZ, WITOLD K · 2011 to 2015
$2.6M
NINDS NIH HHS R01 NS074317
6 · The paper itself

Abstract

To explore pathogenesis in a young Gerstmann-Sträussler-Scheinker Disease (GSS) patient, the corresponding mutation, an eight-residue duplication in the hydrophobic region (HR), was inserted into the wild type mouse PrP gene. Transgenic (Tg) mouse lines expressing this mutation (Tg.HRdup) developed spontaneous neurologic syndromes and brain extracts hastened disease in low-expressor Tg.HRdup mice, suggesting de novo formation of prions. While Tg.HRdup mice exhibited spongiform change, PrP aggregates and the anticipated GSS hallmark of a proteinase K (PK)-resistant 8 kDa fragment deriving from the center of PrP, the LGGLGGYV insertion also imparted alterations in PrP's unstructured N-terminus, resulting in a 16 kDa species following thermolysin exposure. This species comprises a plausible precursor to the 8 kDa PK-resistant fragment and its detection in adolescent Tg.HRdup mice suggests that an early start to accumulation could account for early disease of the index case. A 16 kDa thermolysin-resistant signature was also found in GSS patients with P102L, A117V, H187R and F198S alleles and has coordinates similar to GSS stop codon mutations. Our data suggest a novel shared pathway of GSS pathogenesis that is fundamentally distinct from that producing structural alterations in the C-terminus of PrP, as observed in other prion diseases such as Creutzfeldt-Jakob Disease and scrapie.

Indexed as

MutationAdultAllelesAmino Acid SequenceAnimalsGerstmann-Straussler-Scheinker DiseaseHumansMiceMice, TransgenicMiddle AgedPeptide FragmentsPrion DiseasesProtein DomainsProtein PrecursorsPrPSc ProteinsPeptide FragmentsProtein PrecursorsPrPSc Proteins

Identifiers

PMID29338055
PMCPMC5786331
OpenAlexW2783303684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.